A Phase 3, Open-Label Study Evaluating the Long-Term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis (NCT05444257)
VX20-121-104
This trial is No longer recruiting
Registration number NCT05444257
Program & service
This trial is being run with the Heart & Lung service, and as part of the Respiratory program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Associate Professor Tom Kotsimbos
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR